BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
76 hedge funds and large institutions have $211M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
76
Holding in Top 10
–
Calls
$96K
Puts
–
Top Buyers
| 1 | +$11.3M | |
| 2 | +$7.86M | |
| 3 | +$7.86M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.91M |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$5.12M |
Top Sellers
| 1 | -$5.59M | |
| 2 | -$5.44M | |
| 3 | -$2.92M | |
| 4 |
CC
Centiva Capital
New York
|
-$2.42M |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$498K |